Tokyo Tape
Sign in
← Ono Pharmaceutical

Quarterly report · Q2

4528.TEDINET S100PFS6
Period2022-04-01 → 2022-09-30
Filed2022-11-04
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥216.7bn2022-04-01 → 2022-09-30Cons.Revenue IFRS
Revenue¥110.0bn2022-07-01 → 2022-09-30dCons.Revenue IFRS
Revenue¥361.4bn2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥174.1bn2021-04-01 → 2021-09-30Cons.Revenue IFRS
Revenue¥86.7bn2021-07-01 → 2021-09-30dCons.Revenue IFRS
Operating income¥80.3bn2022-04-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income¥42.1bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Operating income¥58.2bn2021-04-01 → 2021-09-30Cons.Operating profit loss IFRS
Operating income¥28.4bn2021-07-01 → 2021-09-30dCons.Operating profit loss IFRS
Profit before tax¥81.0bn2022-04-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax¥42.0bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Profit before tax¥105.0bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥59.2bn2021-04-01 → 2021-09-30Cons.Profit loss before tax IFRS
Profit before tax¥28.4bn2021-07-01 → 2021-09-30dCons.Profit loss before tax IFRS
Net income (owners)¥62.3bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥32.9bn2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥80.5bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥46.3bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥22.2bn2021-07-01 → 2021-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥62.4bn2022-04-01 → 2022-09-30Cons.Profit loss IFRS
Net income¥32.9bn2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Net income¥46.3bn2021-04-01 → 2021-09-30Cons.Profit loss IFRS
Net income¥22.2bn2021-07-01 → 2021-09-30dCons.Profit loss IFRS
Total assets¥805.0bnat 2022-09-30Cons.Assets IFRS
Total assets¥739.2bnat 2022-03-31Cons.Assets IFRS
Total assets¥771.5bnat 2021-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥94.6bnat 2022-09-30Cons.Liabilities IFRS
Total liabilities¥77.5bnat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥710.4bnat 2022-09-30Cons.Equity IFRS
Net assets / equity¥661.7bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥678.3bnat 2021-09-30Cons.Equity IFRS
Net assets / equity¥639.7bnat 2021-03-31dCons.Equity IFRS
Equity (owners)¥704.5bnat 2022-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥655.9bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥672.6bnat 2021-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥97.8bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥69.1bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥81.1bnat 2021-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥61.0bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥81.0bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥61.8bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥40.4bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥37.9bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow¥6.0bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥5.4bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥15.1bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥60.2bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥15.0bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥127.672022-04-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥67.32022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥162.192021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥92.742021-04-01 → 2021-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥44.512021-07-01 → 2021-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥127.662022-04-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥67.32022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥162.162021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥92.732021-04-01 → 2021-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥44.52021-07-01 → 2021-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio87.5%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio88.7%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio87.2%at 2021-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 613
ItemContextValueUnit
Retirement benefit liability ncl IFRSPrior1YearInstant3322000000JPY
Retirement benefit liability ncl IFRSCurrentQuarterInstant3429000000JPY
Deferred tax liabilities IFRSPrior1YearInstant1009000000JPY
Deferred tax liabilities IFRSCurrentQuarterInstant1005000000JPY
Other non current liabilities ncl IFRSPrior1YearInstant771000000JPY
Other non current liabilities ncl IFRSCurrentQuarterInstant707000000JPY
Non current labilities IFRSPrior1YearInstant11603000000JPY
Non current labilities IFRSCurrentQuarterInstant11223000000JPY
Liabilities IFRSPrior1YearInstant77529000000JPY
Liabilities IFRSCurrentQuarterInstant94632000000JPY
Share capital IFRSPrior1YearInstant17358000000JPY
Share capital IFRSCurrentQuarterInstant17358000000JPY
Capital surplus IFRSPrior1YearInstant17241000000JPY
Capital surplus IFRSCurrentQuarterInstant17080000000JPY
Treasury shares IFRSPrior1YearInstant-74683000000JPY
Treasury shares IFRSCurrentQuarterInstant-54161000000JPY
Other components of equity IFRSPrior1YearInstant51236000000JPY
Other components of equity IFRSCurrentQuarterInstant48841000000JPY
Retained earnings IFRSPrior1YearInstant644754000000JPY
Retained earnings IFRSCurrentQuarterInstant675400000000JPY
Equity attributable to owners of parent IFRSPrior1YearInstant655906000000JPY
Equity attributable to owners of parent IFRSCurrentQuarterInstant704518000000JPY
Non controlling interests IFRSPrior1YearInstant5768000000JPY
Non controlling interests IFRSCurrentQuarterInstant5858000000JPY
Equity IFRSPrior1YearInstant661674000000JPY
Equity IFRSCurrentQuarterInstant710375000000JPY
Liabilities and equity IFRSPrior1YearInstant739203000000JPY
Liabilities and equity IFRSCurrentQuarterInstant805008000000JPY
Revenue IFRSPrior1YTDDuration174077000000JPY
Revenue IFRSCurrentYTDDuration216701000000JPY
Cost of sales IFRSPrior1YTDDuration45567000000JPY
Cost of sales IFRSCurrentYTDDuration53712000000JPY
Gross profit IFRSPrior1YTDDuration128510000000JPY
Gross profit IFRSCurrentYTDDuration162990000000JPY
Selling general and administrative expenses IFRSPrior1YTDDuration37656000000JPY
Selling general and administrative expenses IFRSCurrentYTDDuration42945000000JPY
Research and development expenditure recognized as expense during period IFRSPrior1YTDDuration32552000000JPY
Research and development expenditure recognized as expense during period IFRSCurrentYTDDuration39628000000JPY
Other income IFRSPrior1YTDDuration669000000JPY
Other income IFRSCurrentYTDDuration457000000JPY
Other expenses IFRSPrior1YTDDuration800000000JPY
Other expenses IFRSCurrentYTDDuration602000000JPY
Operating profit loss IFRSPrior1YTDDuration58171000000JPY
Operating profit loss IFRSCurrentYTDDuration80270000000JPY
Finance income IFRSPrior1YTDDuration1422000000JPY
Finance income IFRSCurrentYTDDuration1224000000JPY
Finance costs IFRSPrior1YTDDuration361000000JPY
Finance costs IFRSCurrentYTDDuration478000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1YTDDuration-2000000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYTDDuration3000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2021-07-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass